Nektar Therapeutics (NKTR) saw its stock price soar 5.45% during intraday trading on Friday, reflecting significant positive momentum.
The surge appears to be driven by renewed analyst confidence in the healthcare company. Earlier in the day, Nektar Therapeutics was highlighted as one of the top picks in the healthcare sector by analysts, contributing to increased investor optimism and buying activity.